AdipoPharma is a biotech company developing a novel insulin sensitizer to treat Type 2 diabetes by targeting adipocytes to address insulin resistance.

Eden has raised $12 million to scale its Electrical Reservoir Stimulation (ERS) technology, which aims to enhance permeability in geothermal, geologic hydrogen, geologic carbon storage, and sustainable mining applications, offering improved productivity and environmental benefits.

AOA Dx is a NYC-based company that has raised $17M in funding to develop a detection test for ovarian cancer using their GlycoLocate™ platform, which focuses on glycolipids and tumor marker gangliosides to improve early cancer detection.

Lemurian Labs aims to build a new chip and software that reduces the cost of running AI models by reimagining accelerated computing and minimizing data travel distance, potentially making generative AI models more accessible and cost-effective.